http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013204838-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39c68430bcb778feae2ad4e9640ad0ca |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f286d661508088a4cc8819b80f8708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_decc585f294e99257eff82062e11cf0e |
| publicationDate | 2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013204838-A1 |
| titleOfInvention | Multiple exon skipping compositions for DMD |
| abstract | H:\SXD\Intenvovcn\NRPortbl\DCC\SXD\5064566_.doc-10/04/2013 Provided are antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping, and methods of use thereof to 5 treat muscular dystrophy. o No U) zU 0 :2 00 cc W oL 1ifn |
| priorityDate | 2008-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 494.